Proteome characterization of splenocytes from an Aβpp/ps-1 Alzheimer's disease model

Proteomics

Volumn 14, Issue 2-3, 2014, Pages 291-297

  Cao, Zhiyun ^a   Robinson, Renã A S ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

A pp ps 1 mice; Alzheimer's disease; Animal proteomics; Splenocytes; T cells

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; THY 1 ANTIGEN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CELL ISOLATION; CELL POPULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SPLEEN CELL; TRANSGENIC MOUSE;

ALZHEIMER'S DISEASE; ANIMAL PROTEOMICS; AΒPP/PS-1 MICE; SPLENOCYTES; T CELLS;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, TRANSGENIC; MUTATION; PRESENILIN-1; PROTEOME; SIGNAL TRANSDUCTION; SPLEEN;

EID: 84892868481     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300130     Document Type: Article

References (41)

1. Brookmeyer, R., Johnson, E., Ziegler-Graham, K., Arrighi, H. M., Forecasting the global burden of Alzheimer's disease. Alzheimer's Dement. 2007, 3, 186-191.
2. Russo, C., Schettini, G., Saido, T. C., Hulette, C. et al., Neurobiology: presenilin-1 mutations in Alzheimer's disease. Nature 2000, 405, 531-532.
3. Cohen, R. M., The role of the immune system in Alzheimer's disease. FOCUS: The Journal of Lifelong Learning in Psychiatry 2009, 7, 28-35.
4. Britschgi, M., Wyss-Coray, T., in: Giacinto Bagetta, M. T. C., Stuart, A. L. (Eds.), International Review of Neurobiology, Academic Press, 2007, pp. 205-233.
5. Subramanian, S., Ayala, P., Wadsworth, T. L., Harris, C. J. et al., CCR6: a biomarker for Alzheimer's-like disease in a triple transgenic mouse model. J. Alzheimer's Dis. 2010, 22, 619-629.
6. Jadidi-Niaragh, F., Shegarfi, H., Naddafi, F., Mirshafiey, A., The role of natural killer cells in Alzheimer's disease. Scand. J. Immunol. 2012, 76, 451-456.
7. Zhang, R., Miller, R. G., Madison, C., Jin, X. et al., Systemic immune system alterations in early stages of Alzheimer's disease. J. Neuroimmunol. 2013, 256, 38-42.
8. Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K. et al., Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 1997, 19, 939-945.
9. 2 and kainic acid: implications for Alzheimer's disease. J. Neurochem. 2006, 96, 1322-1335.
10. Abdul, H. M., Sultana, R., St. Clair, D. K., Markesbery, W. R., Butterfield, D. A., Oxidative damage in brain from human mutant Aβpp/ps-1 double knock-in mice as a function of age. Free Radic. Biol. Med. 2008, 45, 1420-1425.
11. Robinson, R. A. S., Cao, Z., Williams, C., Oxidative stress in CD90+ T-cells of Aβpp/ps-1 transgenic mice. J. Alzheimers Dis. 2013, 37, 661-666.
12. Sultana, R., Robinson, R. A. S., Lange, M. B., Fiorini, A. et al., Do proteomics analyses provide insights into reduced oxidative stress in the brain of an Alzheimer disease transgenic mouse model with an M631L amyloid precursor protein substitution and thereby the importance of amyloid-beta-resident methionine 35 in Alzheimer disease pathogenesis? Antioxid. Redox Signal. 2012, 17, 1507-1514.
13. Robinson, R. A. S., Lange, M. B., Sultana, R., Galvan, V. et al., Differential expression and redox proteomics proteome analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-beta peptide of amyloid precursor protein. Neuroscience 2011, 177, 207-222.
14. Lucin, K. M., Wyss-Coray, T., Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 2009, 64, 110-122.
15. Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A. et al., NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 2013, 493, 674-678.
16. Naert, G., Rivest, S., Age-related changes in synaptic markers and monocyte subsets link the cognitive decline of APP(Swe)/PS1 mice. Front. Cell. Neurosci. 2012, 6, 51.
17. Esteras, N., Bartolomé, F., Alquézar, C., Antequera, D. et al., Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)]. Eur. J. Neurosci. 2012, 36, 2609-2618.
18. Pellicanò, M., Bulati, M., Buffa, S., Barbagallo, M. et al., Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production. J. Alzheimer's Dis. 2010, 21, 181-192.
19. Diz, A. P., Truebano, M., Skibinski, D. O. F., The consequences of sample pooling in proteomics: an empirical study. Electrophoresis 2009, 30, 2967-2975.
20. Karp, N. A., Lilley, K. S., Investigating sample pooling strategies for DIGE experiments to address biological variability. Proteomics 2009, 9, 388-397.
21. Cao, Z., Yende, S., Kellum, J. A., Robinson, R. et al., Additions to the human plasma proteome via a tandem MARS depletion iTRAQ-based workflow. Int. J. Proteomics 2013, 2013, 654356.
22. Penzes, P., VanLeeuwen, J. -E., Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease. Brain Res. Rev. 2011, 67, 184-192.
23. Sagar, D., Lamontagne, A., Foss, C. A., Khan, Z. K. et al., Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotoxis at the blood-brain barrier through paracellular transmigration and ERK activation. J. Neuroinflammation 2012, 9, 245.
24. Fiala, M., Zhang, L., Gan, X., Sherry, B. et al., Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Mol. Med. 1998, 4, 480-489.
25. Shalit, F., Sredni, B., Brodie, C., Kott, E., Huberman, M., T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease. Clin. Immunol. Immunopathol. 1995, 75, 246-250.
26. Giménez-Llort, L., Maté, I., Manassra, R., Vida, C., De la Fuente, M., Peripheral immune system and neuroimmune communication impairment in a mouse model of Alzheimer's disease. Ann. NY Acad. Sci. 2012, 1262, 74-84.
27. Jóźwik, A., Landowski, J., Bidzan, L., Fülop, T. et al., Beta-amyloid peptides enhance the proliferative response of activated CD4+CD28+ lymphocytes from Alzheimer disease patients and from healthy elderly. PLoS ONE 2012, 7, e33276.
28. Trieb, K., Ransmayr, G., Sgonc, R., Lassmann, H., Grubeck-Loebenstein, B., APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's disease. Neurobiol. Aging 1996, 17, 541-547.
29. Annerén, G., Gardner, A., Lundin, T., Increased glutathione peroxidase activity in erythrocytes in patients with Alzheimer's disease/senile dementia of Alzheimer's type. Acta Neurol. Scand. 1986, 73, 586-589.
30. Christen, Y., Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 2000, 71, 621s-629s.
31. Robinson, R. A. S., Lange, M. B., Sultana, R., Galvan, V. et al., Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor protein. Neuroscience 2011, 177, 207-222.
32. Ishihama, Y., Oda, Y., Tabata, T., Sato, T. et al., Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell. Proteomics 2005, 4, 1265-1272.
33. Petyuk, V. A., Qian, W. -J., Hinault, C., Gritsenko, M. A. et al., Characterization of the mouse pancreatic islet proteome and comparative analysis with other mouse tissues. J. Proteome Res. 2008, 7, 3114-3126.
34. Marx F, B. I., Pavelka, M., Grubeck-Loebenstein, B., The possible role of the immune system in Alzheimer's disease. Exp. Gerontol. 1998, 33, 871-881.
35. Paulsson, K., Wang, P., Chaperones and folding of MHC class I molecules in the endoplasmic reticulum. Biochim. Biophys. Acta 2003, 1641, 1-12.
36. Leach, M., Williams, D., in: Eggleton, P., Michalak, M. (Eds.), Calreticulin, Springer, USA, 2003, pp. 49-62.
37. Jiang, X., Wang, X., Cytochrome C-mediated apoptosis. Ann. Rev. Biochem. 2004, 73, 87-106.
38. Leuner, K., Schulz, K., Schütt, T., Pantel, J. et al., Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes. Mol. Neurobiol. 2012, 46, 194-204.
39. Solheim, J. C., Class I MHC molecules: assembly and antigen presentation. Immunol. Rev. 1999, 172, 11-19.
40. Vizcaino, J. A., Cote, R.G., Csordas, A. et al., The proteomics identifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 2013, 41, D1063-D1069.
41. Evans, A. R., Miriyala, S., St. Clair, D. K., Butterfield, D. A., Robinson, R. A. S., Global effects of adriamycin treatment on mouse splenic protein levels. J. Proteome Res. 2011, 11, 1054-1064.